Effects of recombinant human endothelial-derived interleukin-8 on hemorrhagic shock in rats

AIM: To study the effects of recombinant human endothelial-derived interleukin-8
(IL-8) on hemorrhagic shock.
METHODS: A profound hemorrhagic shock in rats was produced by exsanguination from
femoral artery with mean arterial blood pressure (MABP) maintained at 5.32 kPa
for 90 min. After transfusion, IL-8 250 micrograms.kg-1 was i.v. injected. Plasma
endothelin-1 (ET-1) and 6 ketoprostaglandin F1 alpha (6-KPGF1 alpha) contents
were determined with radioimmunoassay.
RESULTS: After i.v. IL-8, the MABP in IL-8 group was elevated obviously (P <
0.01), the rat survival 2 h after infusion was increased (P < 0.05). During
profound shock the plasma ET-1 levels were higher (21 +/- 4 vs 8.2 +/- 1.8
ng.L-1, P < 0.01) and the plasma 6-KPGF1 alpha contents lower than those in
normal rats (107 +/- 12 vs 157 +/- 11 ng.L-1, P < 0.01). IL-8 remarkably reduced
the plasma ET-1 levels (10 +/- 4 ng.L-1, P < 0.01) and enhanced plasma 6-KPGF1
alpha contents (368 +/- 16 ng.L-1, P < 0.01).
CONCLUSION: IL-8 has beneficial antishock effects.